Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

If it's not CK5/6 positive, TTF-1 negative it's not a squamous cell carcinoma of lung.

Downey P, Cummins R, Moran M, Gulmann C.

APMIS. 2008 Jun;116(6):526-9.

PMID:
18754327
2.
3.

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.

Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL.

Mod Pathol. 2011 Oct;24(10):1348-59. doi: 10.1038/modpathol.2011.92. Epub 2011 May 27.

4.

The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas.

Kargi A, Gurel D, Tuna B.

Appl Immunohistochem Mol Morphol. 2007 Dec;15(4):415-20.

PMID:
18091384
5.

Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.

Tan D, Li Q, Deeb G, Ramnath N, Slocum HK, Brooks J, Cheney R, Wiseman S, Anderson T, Loewen G.

Hum Pathol. 2003 Jun;34(6):597-604.

PMID:
12827614
6.
7.
8.

ΔNp63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens.

Zhao W, Wang H, Peng Y, Tian B, Peng L, Zhang DC.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):4247-53. eCollection 2014.

9.

Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma.

Puglisi F, Barbone F, Damante G, Bruckbauer M, Di Lauro V, Beltrami CA, Di Loreto C.

Mod Pathol. 1999 Mar;12(3):318-24.

PMID:
10102618
10.

Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.

Khayyata S, Yun S, Pasha T, Jian B, McGrath C, Yu G, Gupta P, Baloch Z.

Diagn Cytopathol. 2009 Mar;37(3):178-83. doi: 10.1002/dc.20975.

PMID:
19170169
11.

Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.

Kim MJ, Shin HC, Shin KC, Ro JY.

Ann Diagn Pathol. 2013 Feb;17(1):85-90. doi: 10.1016/j.anndiagpath.2012.07.006. Epub 2012 Oct 4.

PMID:
23040737
12.
13.

Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.

Kadota K, Nitadori J, Rekhtman N, Jones DR, Adusumilli PS, Travis WD.

Am J Surg Pathol. 2015 Sep;39(9):1170-80. doi: 10.1097/PAS.0000000000000439.

PMID:
25871623
14.

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

Ring BZ, Seitz RS, Beck RA, Shasteen WJ, Soltermann A, Arbogast S, Robert F, Schreeder MT, Ross DT.

Mod Pathol. 2009 Aug;22(8):1032-43. doi: 10.1038/modpathol.2009.60. Epub 2009 May 8.

15.
16.

The diagnostic value of cytokeratin 5/6, 14, 17, and 18 expression in human non-small cell lung cancer.

Chen Y, Cui T, Yang L, Mireskandari M, Knoesel T, Zhang Q, Pacyna-Gengelbach M, Petersen I.

Oncology. 2011;80(5-6):333-40. doi: 10.1159/000329098. Epub 2011 Jul 26.

PMID:
21791943
17.

p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung.

Huang CI, Taki T, Higashiyama M, Kohno N, Miyake M.

Br J Cancer. 2000 Jan;82(2):374-80.

18.

[TTF-1 expression and its diagnostic application in lung carcinomas].

Lin DM, Zou SM, Lü N, Wen P, Liu XY, He ZG.

Zhonghua Zhong Liu Za Zhi. 2004 Oct;26(10):615-7. Chinese.

PMID:
15634524
19.

[Thyroid transcription factor-1 in pulmonary cytology].

Smojver-Jezek S, Vrabec-Branica B, Juros Z, Boras Z, Cucević B, Mazuranić I.

Acta Med Croatica. 2008 Oct;62(4):373-8. Croatian.

PMID:
19205414
20.

Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.

Tsuta K, Tanabe Y, Yoshida A, Takahashi F, Maeshima AM, Asamura H, Tsuda H.

J Thorac Oncol. 2011 Jul;6(7):1190-9. doi: 10.1097/JTO.0b013e318219ac78.

Items per page

Supplemental Content

Write to the Help Desk